Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Statement Issued by the Ministry of Public Health on the Measures Followed with Regard to the People Coming from China

 
The Ministry of Public Health issued the following statement on the measures taken with the travelers coming from China:

Upon recommendation of the World health Organization, the Ministry of Public Health is implementing the following measures with the travelers coming from China through the airport:
  1. Thermal screening through devices put in place at the airport to this end.
  2. When the traveler is exposing fever, he is transferred to the quarantine office where test is carried out on him.
  3. An information form is filled by travelers coming from all the Chinese regions who are on board, so as to follow up on them over the phone for two weeks (the incubation period of the virus) to make sure they do not show any symptoms.
  4. The form should be submitted to the plane crew before taking off. In case the form remained with the traveler for any reason whatsoever, it should be handed out to the quarantine office of the Ministry of Public Health at the airport when leaving the plane.
  5. In the event that a traveler coming China shows any symptoms within 14 days, he will be transferred to Rafik Hariri University Hospital for assessment and quarantined there if need be.
  6. The persons coming from the places where the coronavirus originated (Wuhan and some surrounding areas) will be quarantined at Rafik Hariri University Hospital (like what happened with one traveler so far).
  7. The persons coming from all the other areas in China are required to self-quarantined, and avoid contact with people for 14 days as of the day they leave China. They are also advised to call the Ministry of Public Health for any inquiry.
  8. The lab test for coronavirus, which is now available free of charge at Rafik Hariri University Hospital is conducted according to scientific and medical data determined by the Ministry of Public Health.
  9. The measures taken by the Ministry of Public Health are applied according to the recommendation of the World health Organization.
  10. The citizens are called on to collaborate in the implementation of the scientific and health measures required for the infection prevention.
  11. The Ministry of Public Health calls upon the citizens to act responsibly and not to spread rumors or baseless information.
    ...
    8
ATC Name B/G Ingredients Dosage Form Price
C03DA04 EPLERENONE BIOGARAN G Eplerenone - 50mg 50mg Tablet, coated 1,849,127 L.L
L02BG06 EXEMESTANE BGR G Exemestane - 25mg 25mg Tablet, coated 4,479,027 L.L
J05AF10 ENTECAVIR ARROW G Entecavir - 1mg 1mg Tablet, coated L.L
J05AF10 ENTECAVIR ARROW G Entecavir - 0.5mg 0.5mg Tablet, coated L.L
R06AX22 EBASTINE ARROW G Ebastine - 10mg 10mg Tablet, coated 524,099 L.L
N06AB10 ESCITALOPRAM BIOGARAN G Escitalopram (oxalate) - 10mg 10mg Tablet, coated, scored 678,640 L.L
N06AB10 ESCITALOPRAM BIOGARAN G Escitalopram (oxalate) - 15mg 15mg Tablet, coated, scored 678,640 L.L
N06AB10 ESCITALOPRAM BIOGARAN G Escitalopram (oxalate) - 20mg 20mg Tablet, coated, scored 678,640 L.L
M01AB05 EMIFENAC 50 G Diclofenac sodium - 50mg 50mg Tablet, dispersible 387,027 L.L
V03AC03 ENFEROX G Deferasirox - 500mg 500mg Tablet, dispersible 37,720,158 L.L
N02BE01 EFFERALGAN B Paracetamol - 1g 1g Tablet, effervescent 129,009 L.L
N02AJ06 EFFERALGAN CODEINE B Paracetamol - 500mg, Codeine phosphate - 30mg Tablet, effervescent scored 215,015 L.L
N02BE01 EFFERALGAN B Paracetamol - 500mg 500mg Tablet, effervescent scored 129,009 L.L
M01AB05 EPARDEX G Diclofenac sodium - 50mg 50mg Tablet, enteric coated 223,974 L.L
M01AB05 EPARDEX G Diclofenac sodium - 50mg 50mg Tablet, enteric coated 3,246,979 L.L
C09DX04 ENTRESTO B Valsartan - 26mg, Sacubitril - 24mg Tablet, film coated 6,029,821 L.L
C09DX04 ENTRESTO B Valsartan - 51mg, Sacubitril - 49mg Tablet, film coated 6,029,821 L.L
A10BD19 EMPAGLINE G Empagliflozin - 10mg, Linagliptin - 5mg Tablet, film coated 2,237,050 L.L
A10BD19 EMPALYN G Empagliflozin - 10mg, Linagliptin - 5mg Tablet, film coated 2,237,050 L.L
C09DX04 ENTRESTO B Valsartan - 103mg, Sacubitril - 97mg Tablet, film coated 11,674,240 L.L
A10BD19 EMPAGLINE G Empagliflozin - 25mg, Linagliptin - 5mg Tablet, film coated 2,237,050 L.L
A10BD19 EMPALYN G Empagliflozin - 25mg, Linagliptin - 5mg Tablet, film coated 2,237,050 L.L
A10BD20 EMPAZIMET G Metformin HCl - 1000mg, Empagliflozin - 12.5mg Tablet, film coated 1,840,168 L.L
A10BD20 EMPAZIMET G Metformin HCl - 1000mg, Empagliflozin - 5mg Tablet, film coated 1,840,168 L.L
A10BD21 ENFORZA B Saxagliptin HCl - 5mg, Dapagliflozin - 10mg Tablet, film coated 6,072,824 L.L
B01AF02 ELIQUIS B Apixaban - 5mg 5mg Tablet, film coated 4,183,603 L.L
B01AF02 ELAPIX 5 G Apixaban - 5mg 5mg Tablet, film coated 1,970,969 L.L
B01AF02 ELIQUIS B Apixaban - 2.5mg 2.5mg Tablet, film coated 4,183,603 L.L
B01AF02 ELAPIX 2.5 G Apixaban - 2.5mg 2.5mg Tablet, film coated 1,970,969 L.L
J05AF10 ENTRILIV G Entecavir - 1mg 1mg Tablet, film coated 11,475,203 L.L
    ...
    8
Sitemap
© Copyrights reserved to Ministry of Public Health 2026